Podcast: Play in new window | Download
Listen to Karl Schieneman, Director of Analytics and Review with JurInnov, talk about how important or irrelevant metadata is with Keith Altman, a plaintiff attorney who is often in a position of trying to build out pieces of a case without going on a fishing expedition. Home computers are filled with lots of interesting ESI about custodians but they also raise unique privacy issues. This should be a lively discussion.
Our guest Keith Altman is an attorney with Finkelstein & Partners Mass Tort Department and specializes in pharmaceutical litigation. After consulting on several major pharmaceutical litigations since 1996, Keith was admitted to the Bar of California in 2008. Some of the litigations he has worked on include: Diet Drugs, Rezulin, Propulsid, Accutane, Lariam, Hormone Therapy, Neurontin, Lyrica, Avandia, Meridia, Viagra, and Ortho Evra. Keith is also an expert in electronic discovery and is the founder of the American Association of Justice Electronic Discovery Litigation Group. He is also a member of Working Group One of the Sedona Conference on electronic discovery and is a member of several drafting teams. Keith has lectured throughout the United States on electronic discovery issues. Keith has a B.S., Magna cum Laude in Astronomy/Physics from the State University of New York at Stony Brook. While there, he worked on several research projects as well as a lab conducting experiments in quantum electronics. Keith has done extensive software development for data analysis and litigation support tools.
Recorded 07/08/2010
Our Sponsors
